Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Atkins

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
The Journal of General Virology|November 1, 1985
The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell culturesM C Gates, B J Sheahan, M A O'Sullivan, et al.
Veterinary Pathology|March 1, 1980
Histiolymphocytic lymphosarcoma in the subcutis of two horsesB J Sheahan, G J Atkins, R J Russell, et al.
Journal of Neuroimmunology|April 19, 2002
Avirulent Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunityB Keogh, G J Atkins, K H G Mills, et al.
Neuropathology and Applied Neurobiology|December 1, 1993
Effect of infection with rubella virus on the development of rat cerebellar cells in cultureV A Natale, J F Caffrey, B J Sheahan, et al.
Gene Therapy|September 17, 2004
Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vectorJ W P Smyth, M N Fleeton, B J Sheahan, et al.
Gene Therapy|June 10, 2005
Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12C P Chikkanna-Gowda, B J Sheahan, M N Fleeton, et al.
Gene Therapy|September 23, 2000
Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particlesA M Murphy, M M Morris-Downes, B J Sheahan, et al.
British Journal of Cancer|July 3, 2003
Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapyS Bouralexis, D M Findlay, G J Atkins, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 11, 2012
Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like culturesD Yang, G J Atkins, A G Turner, et al.
Bio/Technology (Nature Publishing Company)|August 1, 1993
Semliki Forest virus expression system: production of conditionally infectious recombinant particlesP Berglund, M Sjöberg, H Garoff, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
The Journal of General Virology|November 1, 1985
The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell culturesM C Gates, B J Sheahan, M A O'Sullivan, et al.
Veterinary Pathology|March 1, 1980
Histiolymphocytic lymphosarcoma in the subcutis of two horsesB J Sheahan, G J Atkins, R J Russell, et al.
Journal of Neuroimmunology|April 19, 2002
Avirulent Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunityB Keogh, G J Atkins, K H G Mills, et al.
Neuropathology and Applied Neurobiology|December 1, 1993
Effect of infection with rubella virus on the development of rat cerebellar cells in cultureV A Natale, J F Caffrey, B J Sheahan, et al.
Gene Therapy|September 17, 2004
Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vectorJ W P Smyth, M N Fleeton, B J Sheahan, et al.
Gene Therapy|June 10, 2005
Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12C P Chikkanna-Gowda, B J Sheahan, M N Fleeton, et al.
Gene Therapy|September 23, 2000
Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particlesA M Murphy, M M Morris-Downes, B J Sheahan, et al.
British Journal of Cancer|July 3, 2003
Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapyS Bouralexis, D M Findlay, G J Atkins, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 11, 2012
Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like culturesD Yang, G J Atkins, A G Turner, et al.
Bio/Technology (Nature Publishing Company)|August 1, 1993
Semliki Forest virus expression system: production of conditionally infectious recombinant particlesP Berglund, M Sjöberg, H Garoff, et al.
Pageof 11